Sandoz

TYRUKO

Manufacturer:

Sandoz

TYRUKO HCPCS:

Q5134

HCPCS Code Descriptor:

Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg

Category:

Q Code

TYRUKO NDCs:

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Tyruko CPT Codes:

Potential CPT administration codes for Tyruko can be found at the following link.

Potential NDC Listing Errors:

Our team has not identified potential listing errors/discrepancies with the NDCs mapped to this HCPCS code

About TYRUKO:

TYRUKO is manufactured by Sandozand aligned to the Q Code: Q5134. TYRUKO is a Neurology medication administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

Q5134 Added Date:

April 1, 2024

Q5134 Effective Date:

April 1, 2024

Q5134 Termination Date:

HCPCS Active

We have not identified a manufacturer-published billing and coding guide for TYRUKO
Our team has not identified a source of patient assistance information for TYRUKO
TYRUKO prescribing information can be found at the link below:
Our team has not yet identified a source of side effect information for TYRUKO.